Skip to Main Content

Author Details

Raffaella Gatta
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
2008
17
12
PMIDPaper TitleJournal TitlePublished Year
32047297Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.Br J Cancer2020
29611184Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma.Br J Haematol2019
31409911Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.Br J Cancer2019
27958379A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia.Pharmacogenomics J2018
28166781Mechanism of action of trabectedin in desmoplastic small round cell tumor cells.BMC Cancer2017
24213580Mode of action of trabectedin in myxoid liposarcomas.Oncogene2014
23332751Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination.Cell2013
22050321NF-Y and the transcriptional activation of CCAAT promoters.Crit Rev Biochem Mol Biol2012
22579713The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells.Exp Hematol2012
22608096A reliable and rapid tool for plasma quantification of 18 psychotropic drugs by ESI tandem mass spectrometry.J Pharm Biomed Anal2012
21304275NF-Y affects histone acetylation and H2A.Z deposition in cell cycle promoters.Epigenetics2011
21614092NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table.Cell Death Dis2011
21739721An acetylation-mono-ubiquitination switch on lysine 120 of H2B.Epigenetics2011
20505338Single nucleosome ChIPs identify an extensive switch of acetyl marks on cell cycle promoters.Cell Cycle2010
18446193An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters.PLoS One2008
18212061The histone-like NF-Y is a bifunctional transcription factor.Mol Cell Biol2008
18940868NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations.Nucleic Acids Res2008
  • 1 - 17 of 17

Recommended Authors

Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Massachusetts General Hospital and Harvard Medical School
Career Start Year 2009
Number of shared co-authors 0
Columbia University
Career Start Year 2009
Number of shared co-authors 0
ULB-Cancer Research Centre (U-CRC), Universite Libre De Bruxelles
Career Start Year 2008
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2007
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Maastricht University Medical Center
Career Start Year 2005
Number of shared co-authors 0
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Princess Margaret Cancer Research Centre
Career Start Year 2003
Number of shared co-authors 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2003
Number of shared co-authors 0
Karolinska Institute
Career Start Year 2003
Number of shared co-authors 0
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 0
Collegeville
Career Start Year 2001
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1999
Number of shared co-authors 0
Smurfit Institute of Genetics, Trinity College Dublin
Career Start Year 1999
Number of shared co-authors 0
Smurfit Institute of Genetics, Trinity College Dublin
Career Start Year 1999
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Radboud Institute for Molecular Science, Radboud University
Career Start Year 1995
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1994
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1991
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 0
Centre Hospitalier Universitaire (CHU) de Quebec-Universite Laval Research Center
Career Start Year 1987
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 0
Penn Epigenetics Institute, Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 0

Collaborators

Universita` degli Studi di Milano
Co-authored papers 11
Universita degli Studi di Milano
Co-authored papers 5
Universita di Torino
Co-authored papers 2
J. David Gladstone Institutes
Co-authored papers 2
National Center for Advancing Translational Sciences
Co-authored papers 2
Co-authored papers 2
Universita degli Studi di Milano
Co-authored papers 1
Global Phasing Ltd
Co-authored papers 1
Laboratory IGBMC (Institute of Genetics and of Molecular and Cellular Biology)
Co-authored papers 1
Universita degli Studi di Milano
Co-authored papers 1
University of Milano
Co-authored papers 1
Institut de Genetique et de Biologie Moleculaire et Cellulaire
Co-authored papers 1
Co-authored papers 1
University of Milano
Co-authored papers 1